Summary
Cis-unsaturated fatty acids (c-UFAs) such as gamma-linolenic acid (GLA), arachidonic acid (AA) and eicosapentenoic acid (EPA) were found to be toxic to human breast tumor cells (ZR-75–1) but not to normal human fibroblasts (41-SK) in vitro. This selective tumoricidal action of GLA, AA and EPA was blocked by anti-oxidants but not by prostaglandin and leukotriene inhibitors suggesting a role of free radicals and lipid peroxidation. On the other hand, LA (linoleic acid), GLA, dihomo GLA (DGLA), EPA and docosahexaenoic acid (DHA) showed cytotoxicity towards human cervical carcinoma cells (HeLa) in vitro. The fatty acid-induced cytotoxic action of HeLa cells could be blocked by antioxidants, calmodulin antagonists, and cyclo- and lipoxygenase inhibitors. These results are in contrast to those observed with ZR-75-1 cells, indicates that though, free radicals are the mediators of the tumoricidal action of fatty acids, the mechanism of their production may be different in different types of tumor cells. In addition intra-tumoral GLA therapy induced substantial decrease in the size of the human gliomas as evidenced by serial CT scan examination. Further, both in vitro and in vivo studies showed that GLA and DGLA can prevent genetic damage induced by radiation and chemicals. These results suggest that specific fatty acids have anti-cancer actions.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Begin, M.E., Das, U.N., Ells, G., Horrobin, D. F. (1985) Prostaglandin. Leukotrienes. Med. 19, 177–186.
Begin, M.E., Ells, G., Das, U.N., Horrobin, D.F. (1986a) J.Natl.Cancer Inst. 77, 1053–1062.
Begin, M.E., Ells, G., Das, U.N.(1986b) Anti Cancer. Res. 6, 291–294.
Booyens, J., Dippenaar, N., Fabri, D. (1984). S. Afri. Med. J. 65, 240–242.
Das, U.N., Begin, M.E., Ells, G., Huang, Y. S., Horrobin, D.F. (1987a) Biochem. Biophys. Res. Commun. 145, 15–24.
Das, U.N., Huang, Y.S., Begin, M.E., Ells, G., Horrobin, D. F. (1987b) Free Radical. Biol. Med. 3, 9–14.
Das, U.N., Huang, Y.S., Begin, X.E., Horrobin, D. F. (1986a) IRCS Xed. sci. 4, 1069–1074.
Das, U.N., Ells, G., Begin, M.E., Horrobin, D.F. (1986b). J. Free Radical. Biol. Med. 2, 183–188.
Das, U.N., Devi, G.R., Rao, K.P., Rao, M.S. (1985a) Prostaglandins 29, 911–920.
Das, U.N., Devi, G.R., Rao, K.P., Rao, M.S. (1985b). IRCS. Med.Sci. 36, 316–317.
Das, U.N., Ells, G., Begin, M. E. (1987c) Nutrition. Rep. Int. 36, 1267–1270.
Das, U.N. (1989a) Nutrition 5, 106–110.
Das, U.N. (1991) Cancer. Lett. 56, 235–243.
Das, U.N. (1990a) In: Biological oxidation Systems, (C.C.Reddy, G.A. Hamilton and K.X.Xadhyastha, Eds), Volume 2, Academic Press, New York, pp. 607–624.
Das, U.N., Padma, M., Sangeetha, P., Ramesh, G., Koratkar R (1990b) Biochem. Biophys.Res.Commun. 167. 1030–1036.
Das, U. N., Devi, G. R., Rao, K. P., Rao, M. S., (1989b) Prostaglandins.38 689–716.
El-Ela, S.H.A., Prasse, K.W., Carrol, R. (1987) Lipids. 22 1041–1044.
Gavino, V. C., Miller, J. S., Ikareblha, S. O., Milo, G.E., Cornwall, D.G. (1981) Journal of Lipid Research 22, 763–769.
Gabor, H., Abraham, S., (1986) J. Natl.Cancer. Inst. 76, 1223–1229.
Jurkowski, J.J., Cave, W. T., Jr. (1985) J. Natl. Cancer. Inst. 74, 1145–1150.
Kobayashi, H., Ojima, M., Satoh, H (1985) Prostaglandins. 29, 255–268.
Karmali, R.A., Marsh, J., Fuchs, C. (1985) J.Nutr.Growth.Cancer. 2, 41–51.
Karmali, R. A., Marsh., J., Fuchs, C. (1984) J. Natl. Cancer. Inst. 73, 457–461.
Renner, H. W., Delincee, H. (1988) Nutrition.Res. 8, 635–642.
Sangeetha, P., Das, U. N., Koratkar, R., Suryaprabha, P (1990a) Free. Radical. Biol. Med. 8, 15–20.
Sangeetha, P., Das, U. N., Koratkar, R. (1990b) Prostaglandins. Leukotrienes. Essential Fatty Acids 39, 27–30.
Sasaki, Y., Iwatani, C., Sakamoto, K., Wakatsuka, H.M., Miyamoto, T., Kawasaki, A. (1984) In: Challenging frontiers for Prostaglandin Research, Abstracts of papers in free communication of Kyoto conference on Prostaglandins (M. Katori, S. Yamamoto and O. Hayaishi, (Eds),Gendai-Iryosha, Tokyo, pp.71.
Seigel, I. Liu, T.L., Yaghoubzadeh, E., Kaskey, T. S., Gleicher, N. (1987) J.Natl. Cancer.Inst. 78, 271–277.
Singh, N. K., Das, U.N., Srivastava, P.K., (1987) J. Assoc. Physicians. India 35, 137–138.
Tanaka, H., Yamamuro, T., Kotoura, Y., Matsumoto, M., Tanaka, C. (1984) In: Challenging frontiers for Prostaglandin Research, Abstracts of free communication of Kyoto conference on Prostaglandins (M.Katori, S.Y Yamamoto and O.Hayaishi, Eds), Gendai-Iryosha, Tokyo, 70–71.
Todo, S., Hashida, T., Shimizu, Y., Imashuku, S., Takamatsu, T. (1984) In: Challenging frontiers for Prostaglandin Research, Abstracts of papers in free communication of Koyoto conference on Prostaglandins (M. Katori, S.Yammoto, and O.Hayaishi, Eds), Gendai-Iryosha, Tokyo, pp72.
Tolnai, S., Morgan, J. P., (1962) Can.J.Biochem.physiol. 40, 869–875.
Zhu, Y.P., Su, Z-W., Li, C-H. (1989) J.Natl.Cancer. Inst. 81, 1302–1306.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Birkhäuser Verlag, Basel/Switzerland
About this chapter
Cite this chapter
Das, U.N. (1992). Anti-Cancer Effects of CIS-Unsaturated Fatty Acids both In Vitro and In Vivo. In: Ong, A.S.H., Packer, L. (eds) Lipid-Soluble Antioxidants: Biochemistry and Clinical Applications. Molecular and Cell Biology Updates. Birkhäuser Basel. https://doi.org/10.1007/978-3-0348-7432-8_39
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7432-8_39
Publisher Name: Birkhäuser Basel
Print ISBN: 978-3-0348-7434-2
Online ISBN: 978-3-0348-7432-8
eBook Packages: Springer Book Archive